Press Releases June 29, 2026 04:15 PM

Elevra Lithium Breaks Ground on Fully Funded North American Lithium Expansion

Elevra Lithium Initiates Expansion of North American Lithium Operations with Full Funding Secured

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
ELVR

Elevra Lithium Limited has commenced the groundbreaking of its fully funded North American Lithium expansion project, aiming to increase spodumene concentrate production capacity by 15-20% and reduce operating costs. The project is expected to complete by mid-2027, enhancing domestic lithium supply critical for electric vehicle and energy storage markets.

Elevra Lithium Breaks Ground on Fully Funded North American Lithium Expansion
ELVR
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Completed a A$275 million capital raise fully funding the North American Lithium expansion.
  • Expected 15-20% increase in spodumene concentrate production capacity by mid-2027.
  • Expansion supports North America's strategic goal to strengthen domestic battery materials supply chains.

BRISBANE, Australia, June 29, 2026 (GLOBE NEWSWIRE) -- North American lithium producer Elevra Lithium Limited (“Elevra” or “Company”) (ASX:ELV; NASDAQ:ELVR) is pleased to announce that it has reached a milestone in the expansion of its North American Lithium (“NAL”) operation with the official groundbreaking of the NAL Expansion project.

The groundbreaking follows the successful completion of Elevra’s May 2026 capital raise, which fully funded the NAL Expansion and strengthened the Company’s balance sheet to support execution of its staged growth strategy1. The groundbreaking was attended by members of the Board of Directors, senior management, and project leadership.

As part of ongoing project execution, equipment for the expansion has been ordered to enable the planned development timeline and reduce schedule risk.

Upon completion in mid-CY27, Stage 1 of the NAL Expansion is expected to deliver a 15-20% increase in annual spodumene concentrate production capacity and a reduction in unit operating costs through improved scale and efficiency2. As North America seeks to strengthen domestic battery materials supply to reduce reliance on external sources, the NAL expansion will deliver increased supply of traceable and transparent lithium to the rapidly growing electric vehicle and energy storage markets.

Elevra’s Chief Executive Officer and Managing Director, Lucas Dow, said: “The groundbreaking of the NAL Expansion marks a milestone for Elevra and reflects the progress we have made since announcing our staged expansion strategy. With funding secured and equipment orders being placed, we are focused on disciplined execution to deliver Stage 1. This expansion will increase production capacity and further strengthen NAL’s position as a strategically important source of lithium supply in North America."

Announcement authorised for release by Elevra’s Managing Director and Chief Executive Officer.

About Elevra Lithium

Elevra Lithium Limited is a North American lithium producer (ASX:ELV; NASDAQ:ELVR) with projects in Québec, Canada, United States and Western Australia.

Elevra’s assets comprise North American Lithium (100%), a 60% stake in the Moblan Lithium Project in Central Québec and the Carolina Lithium project (100%) in the United States.

In Western Australia, the Company holds a large tenement portfolio in the Pilbara region prospective for gold and lithium.

For more information, please visit us at www.elevra.com

1 ASX release 13 May 2026 “Elevra Announces Successful Completion of A$275 Million Institutional Placement”.
2 ASX release 12 May 2026 “Updated NAL Expansion Scoping Study Defines Faster Growth and Lower Costs”.


Risks

  • Execution risk related to project development timelines despite equipment orders.
  • Market demand fluctuations impacting lithium prices and project profitability.
  • Potential regulatory or environmental approvals affecting project progress.

More from Press Releases

Inter&Co Delivers Record 3Q26 Net Income of US$76.1 Million, With Strong Growth, Higher Margin and Better Efficiency Nov 12, 2026 Super League to Report Third Quarter 2026 Financial Results on Monday, November 16, 2026 Nov 12, 2026 UroGen Reports $68.0 Million of ZUSDURI Revenue and Provides Third Quarter 2026 Financial Results and Highlights Nov 4, 2026 BioVie Announces Pricing of $4.74 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules Nov 4, 2026 Jasper Therapeutics Announces 1-for-30 Reverse Stock Split Nov 4, 2026